Abbisko Cayman Ltd
HKEX:2256

Watchlist Manager
Abbisko Cayman Ltd Logo
Abbisko Cayman Ltd
HKEX:2256
Watchlist
Price: 4.18 HKD -9.72% Market Closed
Market Cap: 2.8B HKD
Have any thoughts about
Abbisko Cayman Ltd?
Write Note

Intrinsic Value

Abbisko Cayman Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one Abbisko Cayman Ltd stock under the Base Case scenario is 3.15 HKD. Compared to the current market price of 4.18 HKD, Abbisko Cayman Ltd is Overvalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3.15 HKD
Overvaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Abbisko Cayman Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Abbisko Cayman Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Abbisko Cayman Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Abbisko Cayman Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Abbisko Cayman Ltd

Provide an overview of the primary business activities
of Abbisko Cayman Ltd.

What unique competitive advantages
does Abbisko Cayman Ltd hold over its rivals?

What risks and challenges
does Abbisko Cayman Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Abbisko Cayman Ltd.

Provide P/S
for Abbisko Cayman Ltd.

Provide P/E
for Abbisko Cayman Ltd.

Provide P/OCF
for Abbisko Cayman Ltd.

Provide P/FCFE
for Abbisko Cayman Ltd.

Provide P/B
for Abbisko Cayman Ltd.

Provide EV/S
for Abbisko Cayman Ltd.

Provide EV/GP
for Abbisko Cayman Ltd.

Provide EV/EBITDA
for Abbisko Cayman Ltd.

Provide EV/EBIT
for Abbisko Cayman Ltd.

Provide EV/OCF
for Abbisko Cayman Ltd.

Provide EV/FCFF
for Abbisko Cayman Ltd.

Provide EV/IC
for Abbisko Cayman Ltd.

Show me price targets
for Abbisko Cayman Ltd made by professional analysts.

What are the Revenue projections
for Abbisko Cayman Ltd?

How accurate were the past Revenue estimates
for Abbisko Cayman Ltd?

What are the Net Income projections
for Abbisko Cayman Ltd?

How accurate were the past Net Income estimates
for Abbisko Cayman Ltd?

What are the EPS projections
for Abbisko Cayman Ltd?

How accurate were the past EPS estimates
for Abbisko Cayman Ltd?

What are the EBIT projections
for Abbisko Cayman Ltd?

How accurate were the past EBIT estimates
for Abbisko Cayman Ltd?

Compare the revenue forecasts
for Abbisko Cayman Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Abbisko Cayman Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Abbisko Cayman Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Abbisko Cayman Ltd compared to its peers.

Compare the P/E ratios
of Abbisko Cayman Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Abbisko Cayman Ltd with its peers.

Analyze the financial leverage
of Abbisko Cayman Ltd compared to its main competitors.

Show all profitability ratios
for Abbisko Cayman Ltd.

Provide ROE
for Abbisko Cayman Ltd.

Provide ROA
for Abbisko Cayman Ltd.

Provide ROIC
for Abbisko Cayman Ltd.

Provide ROCE
for Abbisko Cayman Ltd.

Provide Gross Margin
for Abbisko Cayman Ltd.

Provide Operating Margin
for Abbisko Cayman Ltd.

Provide Net Margin
for Abbisko Cayman Ltd.

Provide FCF Margin
for Abbisko Cayman Ltd.

Show all solvency ratios
for Abbisko Cayman Ltd.

Provide D/E Ratio
for Abbisko Cayman Ltd.

Provide D/A Ratio
for Abbisko Cayman Ltd.

Provide Interest Coverage Ratio
for Abbisko Cayman Ltd.

Provide Altman Z-Score Ratio
for Abbisko Cayman Ltd.

Provide Quick Ratio
for Abbisko Cayman Ltd.

Provide Current Ratio
for Abbisko Cayman Ltd.

Provide Cash Ratio
for Abbisko Cayman Ltd.

What is the historical Revenue growth
over the last 5 years for Abbisko Cayman Ltd?

What is the historical Net Income growth
over the last 5 years for Abbisko Cayman Ltd?

What is the current Free Cash Flow
of Abbisko Cayman Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Abbisko Cayman Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Abbisko Cayman Ltd

Balance Sheet Decomposition
Abbisko Cayman Ltd

Current Assets 2.2B
Cash & Short-Term Investments 2.1B
Receivables 5.6m
Other Current Assets 61.4m
Non-Current Assets 68m
PP&E 63.1m
Intangibles 4.9m
Current Liabilities 100.7m
Accrued Liabilities 21.8m
Other Current Liabilities 78.9m
Non-Current Liabilities 19.5m
Long-Term Debt 19.5m
Efficiency

Earnings Waterfall
Abbisko Cayman Ltd

Revenue
497.3m CNY
Cost of Revenue
0 CNY
Gross Profit
497.3m CNY
Operating Expenses
-517m CNY
Operating Income
-19.7m CNY
Other Expenses
3.5m CNY
Net Income
-16.2m CNY

Free Cash Flow Analysis
Abbisko Cayman Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Abbisko Cayman Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Low ROIC
34/100
Profitability
Score

Abbisko Cayman Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Abbisko Cayman Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Abbisko Cayman Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Abbisko Cayman Ltd

Wall Street analysts forecast Abbisko Cayman Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Abbisko Cayman Ltd is 11.31 HKD with a low forecast of 6.83 HKD and a high forecast of 18.9 HKD.

Lowest
Price Target
6.83 HKD
63% Upside
Average
Price Target
11.31 HKD
171% Upside
Highest
Price Target
18.9 HKD
352% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Abbisko Cayman Ltd?

Click here to dive deeper.

Dividends

Abbisko Cayman Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Abbisko Cayman Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Abbisko Cayman Ltd Logo
Abbisko Cayman Ltd

Country

China

Industry

Biotechnology

Market Cap

2.9B HKD

Dividend Yield

0%

Description

Abbisko Cayman Ltd. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of drugs and small molecule oncology therapies. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-10-13. The firm is dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The firm owns two Core Product Candidates, ABSK011 and ABSK091, and 12 other pipeline product candidates. ABSK011 is a potent and highly selective small molecule inhibitor of fibroblast growth factor receptor 4 (FGFR4). ABSK091 is a molecularly targeted product candidate and a highly potent and selective inhibitor of FGFR subtypes 1, 2 and 3. The Company’s products are primarily being developed for hepatocellular carcinoma (HCC), urothelial cancer (UC) and gastric cancer (GC).

Contact

SHANGHAI
Shanghai
Block 3, No. 898, Harley Road, Zhangjiang Hi-Tech Park, Pudong New Area
www.abbisko.com

IPO

2021-10-13

Employees

-

Officers

Founder, Chairman of the Board & CEO
Dr. Yao-Chang Xu
Co-Founder, Jt Co Secretary, Senior VP of Chemistry, Chief Scientific Officer & Executive Director
Dr. Hongping Yu
Co-Founder, Senior VP of Biology, Chief Scientific Officer & Executive Director
Dr. Zhui Chen
Chief Financial Officer
Dr. Zidong Zhang
VP of HR and Operations & Head of Human Resource
Ms. Jia Feng
General Counsel
Mr. Yongyi Li
Show More
VP of CMC & Head of Chemistry, Manufacturing and Controls
Dr. Zhen Zhang
Chief Medical Officer
Dr. Jing Ji
Joint Company Secretary
Ms. Yin Wah Chan FCCA, FCIS, FCS, HKICS
Show Less

See Also

Discover More
What is the Intrinsic Value of one Abbisko Cayman Ltd stock?

The intrinsic value of one Abbisko Cayman Ltd stock under the Base Case scenario is 3.15 HKD.

Is Abbisko Cayman Ltd stock undervalued or overvalued?

Compared to the current market price of 4.18 HKD, Abbisko Cayman Ltd is Overvalued by 25%.

Back to Top